Effect of pharmaceutical care on clinical outcomes of outpatients with type 2 diabetes mellitus
Open Access
- 1 May 2017
- journal article
- research article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 11, 897-903
Abstract
Background: In the People’s Republic of China, outpatients have limited time with their physicians. Thus, compared to inpatients, outpatients have lower medication adherence and are less knowledgeable about their disease. Objective: The objective of this study was to evaluate the effect of pharmaceutical care on clinical outcomes of outpatients with type 2 diabetes mellitus (T2DM). Patients and methods: A randomized, controlled, prospective clinical trial was conducted recruiting a total of 240 T2DM outpatients from Zhongda Hospital, Southeast University. The control group (CG) received only common care from medical staff, whereas the intervention group (IG) received extra pharmaceutical care from clinical pharmacists. Biochemical data such as blood pressure (BP), fasting blood glucose (FBG), glycosylated hemoglobin A1 (HbA1c), and blood lipid were collected before and after 6-month intervention. The primary end points in this study were FBG and HbA1c. Results: After the intervention, most of the baseline clinical outcomes of the patients in IG significantly improved, while only body mass index, diastolic BP, low-density lipoprotein cholesterol, and total cholesterol (TC) improved significantly in patients in the CG. Compared to CG, in IG, there were significant improvements in FBG, HbA1c, TC, the target attainment rates of HbA1c, and BP. Conclusion: Pharmaceutical care provided by clinical pharmacists could improve the control of diabetes of outpatients, and clinical pharmacists could play an important role in diabetes management.Keywords
This publication has 24 references indexed in Scilit:
- Economic Evaluation of a Pharmaceutical Care Program for Elderly Diabetic and Hypertensive Patients in Primary Health Care: A 36-Month Randomized Controlled Clinical TrialJournal of Managed Care & Specialty Pharmacy, 2015
- Impact of a Clinical Pharmacy Program on Changes in Hemoglobin A1c, Diabetes-Related Hospitalizations, and Diabetes-Related Emergency Department Visits for Patients with Diabetes in an Underserved PopulationJournal of Managed Care Pharmacy, 2014
- Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitusBritish Journal of Clinical Pharmacology, 2009
- Effect of pharmacist-led patient education on adherence to tuberculosis treatmentAmerican Journal of Health-System Pharmacy, 2007
- Pharmaceutical care of patients with heart failureBritish Journal of Clinical Pharmacology, 2005
- Impact of a Pharmaceutical Care Program in a Community Pharmacy on Patients with DyslipidemiaAnnals of Pharmacotherapy, 2005
- Evaluation of a Pharmaceutical Care Program for Hypertensive Patients in Rural PortugalJournal of the American Pharmaceutical Association, 2002
- Evaluation of the impact of a pharmaceutical care program in children with asthmaPatient Education and Counseling, 2002
- Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO ConsultationDiabetic Medicine, 1998
- Opportunities and responsibilities in pharmaceutical careAmerican Journal of Health-System Pharmacy, 1990